Pharmaceutical companies hope they’re barking up the right tree in their efforts to develop weight-loss drugs for dogs.
With about 60% of dogs and cats deemed overweight in the U.S., there seems to be a marketplace for such a drug, which would work like Ozempic or Wegovy for humans.
One biotech firm, Okava, expects to bring an animal-friendly version to the public by the end of the decade, according to the New York Post , ultimately giving overweight pets a chance at a leaner, longer life.
While lifestyle changes have traditionally been the preferred option of vets, it’s not always so straightforward.
“Caloric restriction, or fasting, is one of the most well-established interventions for extending the lifespan and improving metabolic health in dogs. But it is also one of the hardes